Report | Puerto Rico Life Sciences Outlook - 2015
Puerto Rico has historically been a key manufacturing location for large biopharmaceutical (biopharma) firms, thanks to lower labor costs and rental rates compared to the United States. Nearly all major life sciences firms have a presence on the island.
The economic downturn and the end of some influential tax incentives on the island have prompted some large biopharma companies to relocate to the mainland of Central and South America. However, we expect mid-sized biopharma firms to stay put due to the benefit of existing infrastructure.
Learn more about what's happening in Puerto Rico's life sciences market, including submarket spotlights, details on tax incentives and more.
To access the report, simply complete the form.